Back to all Publications

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

March 1, 2018

Author(s): Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick CM, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR

Year: March 1, 2018

Recommended for you

Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges

On-Demand Webinar

Why you should select your drug formulation before starting clinical studies

3 Takeaways from the FDA Oligo Guidance You Need to Know

eChalk Talk: Avoid getting “lost in translation” – Increase confidence in translational research using biosimulation

On-Demand Webinar